Search Results - "Chethan, Dev"

Abstract 60: Safety profile of sodium -glucose co-transporter 2 inhibitors in an Indian cohort of patients with Type 2 diabetes mellitus by Inamadar, Soumya, Sonwane, Anand, Praveen, N, Kumar, S, Dev, Chethan, Meshram, K, Sethi, Bipin

“…Background: The use of Sodium-Glucose Co-transporter 2 inhibitors (SGLT2i's) has been robust from the time cardio-vascular outcome (CVOT) trials have…”
Get full text

Abstract 169: A study to evaluate clinical and metabolic profile in a type 1 diabetes cohort receiving Dpp-4 inhibitor plus Sglt2i compared to either drug alone as an adjuvant therapy by Dev, K

“…Introduction: There is always been a need for safe and effective adjuvant therapy in type 1 Diabetes not just for glycemic control but also for cardio-renal…”
Get full text

MON-062 46 XX DSD Due to POR Deficiency by Reddy, Nithin Modhugu, Sethi, Bipin Kumar, Kandula, Srinivas G N S V, Chethan, Dev

“…Background PORD (P450 oxidoreductase deficiency) is a rare form of CAH with marked phenotypic variations due to differences in the degree of steroid hormone…”
Get full text

Abstract 160: A tri prong approach in the management of insulin autoimmune syndrome by Kumar, N S Praveen, Dev, K Chethan, Kandula, Srinivas, Reddy, M Nithin

“…Insulin autoimmune syndrome (IAS) manifests as transient self-limiting endogenous hyperinsulinemic hypoglycemia. It is characterized by the presence of insulin…”
Get full text